Preemptive cyclosporin A in immune‐mediated thrombotic thrombocytopenic purpura

Survivors of immune‐mediated thrombotic thrombocytopenic purpura (iTTP) are exposed to clinical relapses when a disintegrin and metalloproteinase with thrombospondin type 1 repeats, member 13 (ADAMTS13) activity decreases during follow‐up. Although preemptive rituximab usually improves ADAMTS13 acti...

Descripción completa

Detalles Bibliográficos
Autores principales: Comparon, Celine, Galicier, Lionel, Rebibou, Jean Michel, Coppo, Paul, Benhamou, Ygal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10098822/
https://www.ncbi.nlm.nih.gov/pubmed/36271897
http://dx.doi.org/10.1111/ejh.13886

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10098822/
https://www.ncbi.nlm.nih.gov/pubmed/36271897
http://dx.doi.org/10.1111/ejh.13886

Ejemplares similares